Cancer cells can dodge chemotherapy by entering a type of “active hibernation” that enables them to weather the stress induced by aggressive treatments, according to a new study by scientists at Weill Cornell Medicine.
A collaboration of researchers led by Cornell has been awarded $22.5 million from the National Science Foundation to continue gaining the fundamental understanding needed to transform the brightness of electron beams available to science, medicine and industry.
Medical student Nina Acharya ’19, one of 11 newly elected Rhodes Scholars from Canada, will go to Oxford University next fall to study children’s nutrition interventions in vulnerable communities.
In the 1800s, Americans were targeted with advertisements for what were often considered “cure-all” medicines, presented in colorful trade cards – now part of a Weill Cornell Medicine collection.
Supported by a grant from the NIH, researchers from Weill Cornell Medicine and the University of Miami will study ways to use wastewater as an early warning and mapping system for genetic variants of the virus that causes COVID-19.
A single protein derived from a common strain of bacteria found in the soil will offer scientists a more precise way to edit RNA, according to new Cornell food science research.
A group of immune cells that normally protect against inflammation in the gastrointestinal tract may have the opposite effect in multiple sclerosis and other brain inflammation-related conditions, according to a new study by Weill Cornell Medicine researchers.
Rockland County, New York officials declared a state of emergency today and banned anyone who is under 18 years of age and unvaccinated against the measles from public spaces for 30 days or until they receive the MMR vaccination. Cynthia Leifer, professor of immunology at Cornell University, says the general public is at risk when parents choose not to vaccinate their children and compares the situation to the recklessness of drunk drivers.
A cellular protein whose normal function appears to suppress bone formation may be a potential new target for treating osteoporosis, according to a collaborative study led by Weill Cornell Medicine and NewYork-Presbyterian researchers.
